SLXN

Silexion Therapeutics
SLXN

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$6
135% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Litchfield Hills
Litchfield Hills
Theodore O'Neill
0% 1-yr SLXN win rate
15 Dec ‘25 2 days ago